Our Mission on Covid-19

Control is only possible through mass testing.

Testing helps us with two stages of controlling the pandemic. The first is the diagnosis of infected patients via virus-specific molecular tests. The second is identifying recovered patients via immunochromatography (rapid test).

While getting ready for the post-Covid-19 state, we understand the importance of being technologically prepared for the post corona stage and the future pandemics. That’s why we started to develop Sars-Cov-2 specific diagnostic rapid tests and virus-specific anti-human antibody rapid tests, and a standardized screening device.

Our Covid-19 Solutions

The GNZ-CVD-19 Ab Test is a microfluidic immunofluorescence assay for the qualitative detection of SARS-CoV-2 antibodies in whole human blood or serum to indicate recent or prior infection. The test chip is used with the Genzpro POC device, delivering results in 8-10 minutes, using cloud-based platforms to integrate health system networks and transfer patient data.

Genzpro’s microfluidic chip is designed for single use of serological tests using a finger blood drop specimen that detects the Covid-19 antibodies against Covid-19. Inside of the chip is coated with anti-IgM, IgG antigens that specifically catch human IgG antibodies. The test takes 8-10 minutes in total and gives quantitative results using the GenzPro test device. The test report might be sent to the client or doctor automatically as requested. GenzPro Antibody Rapid test shows the immune response of patients against the Covid-19 virus after 2-14 weeks from the infection in a reliable way.

The GNZ-CVD-19 Ab Test is designed to be used in community care settings to identify individuals with an adaptive immune response to COVID-19, indicating recent or prior infection, antibody therapies, or vaccination.

Easy to implement in point of care settings
Time to result in 10 minutes
Highly accurate

Genz Pro device is a portable easy to use testing system optimized for outdoor use. Genz Pro reads the Ag/Ab quantity using Genz pro test chips in minutes from the client’s blood or nasal swab specimen. Test results automatically can be stored in the device and/or sent to the doctor or patients via mobile or email. Genz Pro device is a smart solution for reliable testing, and it prevents virus contamination.

The Genzpro Platform is an innovative, nextgen point of care diagnostic system that combines a small, compact device, an advanced low-cost test chip, and seamless connectivity.

The platform and tests are created on the same principles as gold standard lab analyzer systems to produce accurate results across many parameters in a portable, easy-to-use point of care solution.

Request Demo